Detalles de la búsqueda
1.
Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
Circulation
; 147(7): 575-585, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780380
2.
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
Lancet
; 402(10416): 1979-1990, 2023 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898137
3.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
N Engl J Med
; 385(18): 1643-1655, 2021 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449185
4.
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study.
Catheter Cardiovasc Interv
; 103(2): 286-294, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38145467
5.
Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
Circulation
; 145(10): 724-738, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34747186
6.
Incidental detection of malignancy during preprocedural workup for transcatheter aortic valve implantation: A longitudinal cohort study.
Am Heart J
; 261: 51-54, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37011854
7.
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials.
Am Heart J
; 263: 73-84, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192697
8.
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI.
Am Heart J
; 265: 153-160, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572785
9.
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort.
J Med Virol
; 95(7): e28904, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386901
10.
Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.
Catheter Cardiovasc Interv
; 101(4): 687-700, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807456
11.
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.
Respiration
; 102(2): 120-133, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566741
12.
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Eur Heart J
; 43(33): 3100-3114, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580836
13.
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
Circulation
; 144(15): 1196-1211, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455849
14.
Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.
Am Heart J
; 244: 94-106, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34788603
15.
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
Am Heart J
; 247: 33-41, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092722
16.
Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv
; 99(6): 1908-1917, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35170846
17.
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
Europace
; 24(9): 1441-1450, 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253840
18.
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
JAMA
; 327(18): 1771-1781, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368058
19.
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
Circulation
; 142(5): 441-454, 2020 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32795098
20.
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Am Heart J
; 238: 33-44, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951415